23 min read

Positioning and Outlook - 2026-07-25

General & impersonal research commentary. Not investment advice.

Published 2026-07-25

Geopolitical escalation pushed Brent back to $100 and lifted defense names on record order backlogs, while tightening high-yield spreads and steady buybacks kept credit conditions supportive even as the model's cash signal stayed in place.

Recent Events

Geopolitics set the tone over the past few weeks, with Brent touching $100 again as Houthi attacks threatened a further supply squeeze, and defense names surging on the same theme, Lockheed Martin jumped 10% on missile demand and a record $230 billion backlog, while RTX gained 7% on its own earnings beat. In Tokyo, Bank of Japan members signaled a push for regular rate increases to control inflation, while in Washington the calendar brought a run of Fed commentary, including Warsh's semiannual monetary policy report to Congress and remarks from Cook and Bowman. Credit conditions stayed supportive, with high-yield spreads shifting from flat to tightening even as the data flagged holding cash, and corporate buybacks held steady with roughly 8,280 active programs totaling about $3.37 trillion over the trailing twelve months. On the single-name front, AMD agreed to sell Anthropic tens of billions of dollars in AI servers and invest up to $5 billion in the startup, capping a stretch that leaves plenty for the days ahead to resolve.

Macro & policy
2026-07-23Bank of Japan Members Signal Push for Regular Rate Increases to Control Inflation
2026-07-24Lockheed Martin Jumps 10% as Missile Demand and Record $230 Billion Backlog Drive Earnings Beat - FXLeaders
2026-07-24RTX Stock Jumps 7% as Missile Demand and Aerospace Recovery Drive Earnings Beat - FXLeaders
2026-07-23Brent Hits $100 Again as Houthi Attacks Threaten Further Supply Squeeze
Credit & corporate
2026-07-14Buybacks: 8279 active, $3371B TTM
2026-07-14HY OAS Weekly: FLAT → hold cash
2026-07-23Buybacks: 8281 active, $3373B TTM
2026-07-23HY OAS Weekly: TIGHTENING → hold cash
On the calendar
2026-07-15Cook, Economic Outlook
2026-07-14Warsh, Semiannual Monetary Policy Report to the Congress
2026-07-14Bowman, Responsible Innovation and Financial Inclusion
Notable news
2026-07-22AMD to sell Anthropic tens of billions in AI servers, invest up to $5 billion in startup
2026-07-228-K Entry into Material Agreement; Results of Operations (Earnings); Regulation FD Disclosure; Other Events
2026-07-088-K Entry into Material Agreement; 5.03; Other Events

Upcoming Events

The calendar's center of gravity is a run of central-bank decisions compressed into just over a week, the FOMC announces policy on July 29, the Bank of Japan follows two days later, and the Bank of England lands on August 6, leaving the tape little room to digest one outcome before the next arrives. The PBOC's loan prime rate fixing on August 20 rounds out the macro spine a fortnight later. Around that core sits a dense supporting slate: more than 2,100 earnings reports are scheduled for the window, opening with Verizon and a batch of smaller names on July 24, while mid-sized Treasury supply in the form of a 5-year note and 26-week bill auction tests demand on July 27. The same stretch also brings a cluster of moderate-impact clinical readouts from JNJ, Roche, Bristol-Myers Squibb, Novavax, and Pfizer, giving single-name biotech and pharma its own catalysts to trade around while the rate decisions dominate the broader tape.

2026-07-24 phase3 readout: Icotrokinra (JNJ) (US)
2026-07-25 phase2 readout: SIRT-Y90 with Atezolizumab + Bevacizumab (RHHBY) (US)
2026-07-25 phase3 readout: BMS-986165 (BMY) (US)
2026-07-26 phase3 readout: CIC Vaccine Co-formulated tNIV2, SARSCoV-2 rS and Matrix-M Adjuvant (NVAX) (US)
2026-07-27 26-Week BILL auction (US)
2026-07-27 5-Year NOTE auction (US)
2026-07-27 phase3 readout: Palbociclib 125mg (PFE) (US)
2026-07-29 FOMC monetary policy decision (US)
2026-07-31 Bank of Japan Monetary Policy Meeting (JP)
2026-08-06 Bank of England MPC monetary policy decision (UK)
2026-08-20 PBOC Loan Prime Rate (LPR) fixing (CN)
Plus 2110 corporate earnings reports scheduled in the window.

Macro Projections

The outlook leans range-bound across all three horizons, but the conviction behind that lean thins as the horizon lengthens, what follows is the chain of mechanisms behind each band, with the nearer links carried at higher confidence than the multi-year one. In the near term, the calm is unusually well documented: the credit regime model (a statistical classifier of US credit conditions) sits deep in calm with a posterior near 1.0, high-yield spreads, the extra yield junk bonds pay over Treasuries, hold around 271bp and are stable-to-tightening, the VIX implied-volatility index sits near 17, and the composite macro-signal score stands at roughly 73. That benign tape, however, runs straight into a dense cluster of binary events, the FOMC on 7/29, GDP and PCE on 7/30, and the BoJ on 7/31, which caps reliable forecastability at about two to three weeks, and the model's own stability read carries a confidence of just 0.19, so the near-term lean is held at only moderate conviction. The months-to-quarters view keeps the same range-bound lean at similar confidence, carried by a market-clearing credit regime (modal probability 0.87), an early-stage credit cycle, and a positively sloped curve with real yields rising, the 10-year inflation-protected yield at 2.32 and accelerating, a combination consistent with a muddle-through expansion rather than repression or crisis. The live risk to that middle band is fiscal: the term-premium and fiscal-dominance signal is currently inactive, with the ACM estimate of the term premium (the extra yield demanded to hold long bonds rather than rolling short ones) at +69bp, but it remains on watch, and at that distance only months-scale drift is honestly claimable. On the secular band the reasoning shifts from cycle to valuation: US equities sit at a cyclically adjusted price-earnings ratio of 41.5, the 98th percentile of history, implying roughly 2.4% real over the coming decade, against cheaper emerging and developed ex-US markets. That gap, alongside the structural term-premium and financial-repression watch, is why the longer view favors real assets and non-US exposure over broad US equity beta, though valuation is a base-rate prior, not a timing signal, and CAPE is close to useless inside three years. Read as one chain, the near-term calm is the early edge of a cyclical muddle-through resting on a secular valuation stretch, and the fade in confidence from weeks to years is part of the mechanism itself, not a footnote.

Near term  expires Aug 24, 2026
HY OAS closes at or above 3.00% on at least one day within the next 30 days (from 2.77% on 2026-07-23).
Cross-validated: geopolitical (GPR 191.8, Hormuz near closure, Red Sea blockade) + volatility (VIX 18.7 accelerating_positive, term structure 0.914 in backwardation, SKEW 145.95) against a credit market that has only crept +9bp in a week. The hy_oas_widen_spx_drawdown mechanism edge (hit rate 0.50, n=52) has not yet triggered, and Brent >$100 with new tariffs pressures CCC funding costs.
Cyclical  expires Oct 23, 2026
The Fed leaves the policy rate unchanged, no hike and no cut, at both the July 29 and September 2026 FOMC meetings (muddle-through).
The status-quo scenario, cross-validated across three domains: the fed model puts hold propensity at 86% (intervention propensity 14.5%, rising only slowly); Kalshi prices a cut before 2027 at just 17.9%; and the WSJ week-ahead flow expects a July hold. Hike chatter is real (admitted narrative edges: oil→hike-probability, low jobless claims→rate expectations), which is why confidence is moderate not high, an oil-loc…
Cyclical  expires Oct 23, 2026
The August 2026 headline CPI YoY print (released mid-September) comes in at or above 3.8%.
The strongest cross-validated claim in the substrate: Kalshi prices this at 90% (repriced +62pts in 24h); the oil_supply_shock_headline_cpi mechanism edge carries a 0.86 hit rate (n=7, already_priced 0.6); and the "oil up a third this month → inflation" narrative edge is a fresh known_firing of that exact catalog edge. Brent >$100 with Hormuz and Bab el-Mandeb both impaired makes the pass-through mechanical.
Near term  expires Aug 24, 2026
VIX closes above 22 on at least one day within the next 30 days (from 18.7 on 2026-07-23).
Anchored to the Tier-1 volatility domain: VIX 18.7 and accelerating_positive (+1.97 w/w), term structure 0.914, below 1, backwardation, and VVIX 100.7, against a dense catalyst run (FOMC 7/29, GDP/PCE 7/30, BoJ 7/31) plus Pentagon mobilization for "something much bigger." Sentiment at 65 mild greed (Tier-3) implies complacency with room to reprice. Moderate: MOVE at 76.8bp stable argues the rates leg is not yet part…
Cyclical  expires Jan 21, 2027
Brent front-month crude averages above $90/bbl over the next 180 days, the supply-disruption premium persists rather than fully retracing to pre-escalation levels.
Geopolitical + narrative + prediction domains: Hormuz near closure plus the Red Sea blockade constitute a dual-chokepoint impairment; the geopolitical_energy_closure edge (hit rate 0.62, n=89) is firing repeatedly in the news corpus. The gap: Kalshi prices Brent >$92.50 on 7/27 at only 48% and WTI >$92 on Nov 3 at 39% despite >$100 spot, the crowd expects fast normalization.
Secular  expires Jul 25, 2027
Developed-ex-US plus EM equities outperform US large-cap equities in total return over the next 365 days.
Valuation anchor: ex-US earnings yields of 5.31% (developed) and 5.67% (EM) versus 3.72% US, with US CAPE at 40.4 implying ~2.5% 10y real return. COT shows lev money −2.45z short NDX while US-centric costs mount (10–12.5% forced-labor tariffs, EU retaliation risk).

Positioning

With the credit backdrop calm and high-yield spreads near 2.68%, the model portfolio sizes each position in proportion to conviction: every name's weight is set by its screening-kernel composite score, a modelled blend of expected upside drift against drawdown probability, so the strongest scores carry the largest equity weights while low-conviction names stay small. Beneath that sizing, overall risk appetite is calibrated by a handful of structural channels, merger-arb completion, oil-supply shocks feeding into headline CPI, and commodity production losses moving agricultural prices, each treated as a weighable input carried with its full historical base rate, misses counted, and discounted for what the market already prices. The resulting weights, and the dossier behind each holding, are set out in the model-portfolio table below.

NameConviction scoreModelled drift
CAF
-0.24
+2.1%
BDL
-0.27
+1.9%
STK
-0.29
+3.1%
XYF
-0.34
-4.2%
UG
-0.34
-0.5%
NEON
-0.40
-4.3%
merger arb completion → merger target arb spread · 89% base rate · n=47 · 60% pricedoil supply shock headline cpi → headline CPI · 86% base rate · n=7 · 60% pricedcommodity production loss → agricultural commodity · 80% base rate · n=5 · 40% priced

Model Portfolio

The model portfolio leads with its largest single line in cash, a money-market sleeve held back as dry powder for staged deployment into the cascade as the credit and volatility picture resolves. What is deployed leans heavily on structural real-asset exposure: inflation-linked Treasuries spread across SCHP, VTIP and LTPZ carry the financial-repression thesis, while gold through IAU and a diversified commodity basket via DBC supply the geopolitical and monetary-stress hedges. The book's remaining risk expression sits in the rotation bucket, where the QUAL quality-equity sleeve carries its tilt to the AI capex cycle.

Cash 20.7%Inflation-linked 11.5%Equity 10.0%Other 9.0%Gold & metals 4.0%
NameWeightThesis
Cash · 20.7%
Money Market
16.9%
money-market / cash
DBC
3.8%
commodities other
Inflation-linked · 11.5%
SCHP
5.6%
inflation-linked Treasuries
VTIP
3.4%
inflation-linked Treasuries
LTPZ
2.6%
inflation-linked Treasuries
Equity · 10.0%
QUAL
5.1%
global quality equity
CAF
1.2%
global quality equity
NEON
1.0%
global quality equity
UG
0.8%
global quality equity
STK
0.6%
global quality equity
UIS
0.5%
global quality equity
XYF
0.4%
global quality equity
SPRO
0.3%
global quality equity
BDL
0.1%
global quality equity
Gold & metals · 4.0%
IAU
2.4%
gold / precious-metals
GDX
0.9%
gold / precious-metals
WPM
0.3%
gold / precious-metals
FNV
0.3%
gold / precious-metals
SLV
0.1%
gold / precious-metals
Other · 9.0%
COPX
0.6%
critical materials defense
FCX
0.6%
critical materials defense
URA
0.6%
critical materials defense
SCCO
0.5%
critical materials defense
LMT
0.5%
critical materials defense
RTX
0.4%
critical materials defense
NOC
0.4%
critical materials defense
URNM
0.4%
critical materials defense
CCJ
0.4%
critical materials defense
GD
0.3%
critical materials defense
MP
0.3%
critical materials defense
XAR
0.3%
critical materials defense
NTR
0.3%
critical materials defense
UEC
0.3%
critical materials defense
UUUU
0.3%
critical materials defense
ALB
0.2%
critical materials defense
MOS
0.2%
critical materials defense
LDOS
0.2%
critical materials defense
TECK
0.2%
critical materials defense
CF
0.2%
critical materials defense
ITA
0.2%
critical materials defense
LIT
0.2%
critical materials defense
SQM
0.2%
critical materials defense
REMX
0.2%
critical materials defense
HWM
0.1%
critical materials defense
GE
0.1%
critical materials defense
HII
0.1%
critical materials defense
LEU
0.1%
critical materials defense
LAC
0.1%
critical materials defense
ICL
0.1%
critical materials defense
DNN
0.1%
critical materials defense
NXE
0.1%
critical materials defense
Position notes
DBC 3.8%
Full research note
Invesco DB Commodity Index Tracking Fund is an ETF tracking a diversified commodity index via futures contracts.
CAF 1.2%
Full research note
Closed-end fund investing in Chinese equities, managed externally.
Bull case · As a closed‑end fund, CAF may trade at a discount to net asset value, providing a potential mean‑reversion opportunity if the discount narrows. Additionally, a broad rally in Chinese equities could lift the fund’s share price.
Bear case · The fund’s returns are purely a beta play on Chinese equities, which face geopolitical, regulatory, and macroeconomic headwinds. Persistent management fees erode returns, and the fund trades at a premium/discount that can widen unpredictably. Lack of competitive advantage means no structural compounding.
Key risks
• Geopolitical risk from US‑China tensions impacting Chinese equities
• Regulatory risk from Chinese government intervention in markets
• Discount/premium volatility typical of closed‑end funds
• Management fees erode long‑term returns
• Single‑country concentration increases drawdown risk
NEON 1.0%
Full research note
Neonode is a nano-cap technology company with negligible revenue (USD 0.6M), persistent operating losses (op margin -3.37x), and no discernible durable competitive advantage. our model's multi-horizon expected returns are negative to near-zero, with high downside risk (p_dd_030 reaches 19% at 10y), making it unsuitable for long-horizon compounding.
Bull case · The company holds a large net cash position (USD 23.0M) relative to its market cap (USD 26.3M), providing a floor on equity value if assets are returned to shareholders. A sudden licensing deal or acquisition of its optical touch IP could unlock value, but this is a speculative outcome, not a structural moat.
Bear case · Neonode's core technology faces obsolescence risk and intense competition from well‑capitalized players. With no revenue growth and ongoing cash burn (FCF USD -2.1M in Q1), the cash pile will erode over time. our model's negative momentum signal (idiosyncratic -0.225 at medium horizons) suggests continued price weakness.
Key risks
• Nano‑cap illiquidity amplifies drawdowns and exit costs.
• Technology disruption: optical touch solutions may become irrelevant as display technologies evolve.
• No structural competitive advantage — the business lacks scale, switching costs, or regulatory barriers.
• Cash burn: despite net cash of USD 23M, quarterly FCF of -USD 2.1M implies a runway of ~11 quarters, after which dilution or asset sales become necessary.
UG 0.8%
Full research note
Specialty cosmetic ingredients and pharmaceutical manufacturer with high customer concentration.
Bull case · UG enjoys structurally high margins and returns that hint at a genuine competitive advantage in a specialized niche. With a pristine balance sheet (cash USD 736K, no debt) and a price-to-earnings of 13.4, the market may be undervaluing its consistent cash generation. If the business can compound even modestly over a long horizon, the current valuation could provide an attractive entry point for a patient investor willing to accept nano-cap volatility.
Bear case · Revenue is minuscule at USD 2.87M per quarter, making the company highly vulnerable to any customer loss, product disruption, or key-person departure. Nano-cap illiquidity adds a further layer of risk, with wide bid-ask spreads and the potential for catastrophic drawdowns during market stress. Even with high margins, the absolute dollar profits are small, limiting reinvestment capacity and raising the risk of permanent capital impairment if the underlying franchise deteriorates.
Key risks
• Extreme illiquidity and nano-cap fragility: minimal daily volume leads to high trading costs and difficult exits.
• Tiny revenue base (USD 2.87M quarterly) amplifies the impact of any operational or competitive headwind.
• No institutional coverage or analyst following limits price discovery and may result in prolonged mispricing.
• Potential for key-man risk in a micro-organization with likely thin management depth.
• Even with solid margins, the absolute dollar profit pool is too small to fund meaningful reinvestment or withstand sustained adversity.
STK 0.6%
Full research note
Closed-end mutual fund investing in tech growth stocks, managed by Columbia Management.
Bull case · A sustained tech rally driven by AI breakthroughs could lift NAV and narrow the discount. The fund’s covered-call strategy may generate attractive income in a flat market. If the discount reverts to historical narrow levels, investors could capture double-digit returns from convergence alone.
Bear case · Technology stocks face a peak-AI-capex digestion risk that could trigger a 20-30% drawdown, exacerbated by passive-flow concentration. STK’s CEF structure adds discount widening and leverage drag, compounding NAV losses. our model's high downside risk (80% chance of >5% drawdown over 10 years) underscore the asymmetric downside.
Key risks
• Discount/premium volatility erodes returns relative to NAV, especially during tech selloffs.
• Technology sector concentration magnifies losses from AI capex cycle downturn or regulatory shifts.
• Fee drag from active management and CEF expenses reduces net returns vs. passive alternatives.
• Liquidity risk: low trading volume in a small-cap CEF can exacerbate price dislocations.
• Interest rate sensitivity: if leveraged, rising rates increase borrowing costs and pressure NAV.
FCX 0.6%
Full research note
Freeport-McMoRan is a global copper and gold miner with significant operations in Indonesia.
SCCO 0.5%
Full research note
Southern Copper is a low-cost copper producer with exceptional margins and a robust project pipeline, but its current valuation more than prices in these strengths, leaving it vulnerable to macro and political headwinds.
Bull case · Structural copper demand from electrification, renewable energy, and AI data centers supports long-term price appreciation; SCCO's industry-leading margins (gross margin ~59%, operating margin ~58%) and low cash costs provide a wide moat; the Tía María project and strong free cash flow generation (FCF margin ~29%) offer additional upside if copper prices remain elevated and the US-Iran peace deal temporarily eases inflation fears, potentially lowering the dollar.
Bear case · The stock trades at a significant premium to its sector (P/E 29.2 vs. peer median 26.1; P/B 12.3 vs. 2.2) with a consensus analyst target ~15% below current price and a majority of sell/underperform ratings; a potential copper demand slowdown from China's economic struggles or renewed trade war escalation, combined with a hawkish Fed holding rates high for longer, could compress multiples and trigger a sharp correction. Additionally, the recent Iran peace deal may reduce the 'safe-haven' premium that had supported commodity currencies and metals.
Key risks
• Severe valuation overhang: SCCO is priced for perfection, leaving no margin of safety if copper prices retreat or costs rise.
• Geopolitical and regulatory risks in Peru, including potential mining tax overhauls and anti-mining protests that could disrupt operations.
• Macro sensitivity to a strong US dollar (the DXY remains elevated) and a potential Chinese economic slowdown, both of which would directly pressure copper prices.
• Execution risk at Tía María, a greenfield project with a history of community opposition; delays or cost overruns could erode returns.
• Elevated short interest (12.1% of float, 9.0 days to cover) signals significant bearish sentiment, increasing vulnerability to a downside catalyst-driven squeeze rather than an upside one.
UIS 0.5%
Full research note
Unisys provides IT services with a focus on international operations and installed base dependency.
Bull case · Gross profit of $112.5M on $437.6M revenue provides some gross margin buffer, and $380M cash could fund restructuring; an operational turnaround or asset sale could unlock value, but no evidence exists.
Bear case · Negative equity of -$300M, net income loss of -$35.8M, and negative free cash flow of -$25.5M indicate severe financial distress; high debt of $765M and ongoing losses risk bankruptcy or forced dilution in a capital-intensive, commoditized sector.
Key risks
• Bankruptcy risk from negative equity and persistent losses
• Dilution risk from potential equity raises at distressed prices
• Competitive pressures in the IT services industry limit margin recovery
• Micro-cap illiquidity magnifies downside risk
• No near-term catalysts to reverse negative momentum or improve fundamentals
XYF 0.4%
Full research note
X Financial is an online personal finance company in China, offering credit and home equity loans.
Bull case · At 0.5× EV/EBITDA and a P/B of 0.2, the market is pricing in a near‑demise. Even a modest normalisation of net margins to 5–6% would imply a 3–4× re‑rating. The company’s net cash (CNY 667 M) covers a large portion of the market cap, limiting absolute downside. A calm US credit regime and tightening HY OAS provide a supportive backdrop for risk‑on micro‑cap exposure.
Bear case · our model's negative 1‑month, 3‑month and 9‑month expected upside signals that price momentum remains deeply broken, possibly reflecting credit deterioration in the loan book or regulatory headwinds for Chinese online lending platforms. Net margin of 3.2% and an Altman Z in the distress zone (<1.8) suggest the business is fragile and that the market’s discounted valuation may be rational rather than an opportunity. The EM crisis regime adds uncertainty for China‑facing ADRs.
Key risks
• Chinese regulatory risk for online lending and fintech platforms could disrupt the business model.
• Credit cycle deterioration eroding asset quality and pushing the company into losses.
• Micro‑cap liquidity risk and vulnerability to a disorderly carry‑unwind, where forced liquidations hammer the most illiquid names.
• Financial distress – Altman Z‑score of 1.44 is well into the grey zone, with a high probability of solvency issues if earnings do not recover.
RTX 0.4%
Full research note
Aerospace and defense systems provider with high government revenue concentration.
CCJ 0.4%
Full research note
Cameco is a top uranium producer supplying fuel to nuclear utilities globally.
Bull case · The strongest bull case hinges on the accelerating AI data center power buildout and Cameco's strategic downstream integration. Recent catalysts include Cameco's June 2026 move to increase its stake in the tier-one Cigar Lake mine to 57.4%, alongside Westinghouse (49% owned by Cameco) securing a central role in an $80 billion U.S. government partnership to deploy AP1000 reactors. Analysts are reiterating buys on the recent dip, citing long-term uranium contract prices hitting $90/lb in Q1 2026—the highest level since 2008—which structurally insulates the company from spot market volatility.
Bear case · The bear case focuses on severe valuation overhang and near-term execution friction. Trading at over 90x trailing earnings, the stock is highly vulnerable to multiple compression if uranium spot prices stall or if AI capex digestion delays actual reactor deployments. Furthermore, recent supply chain disruptions—such as the May 2026 bridge collapse in northern Saskatchewan that temporarily halted Key Lake and McArthur River supply lines—highlight the operational fragility of remote mining assets.
Key risks
• Severe valuation overhang leaving no margin of safety if uranium prices plateau or hyperscaler nuclear timelines slip.
• Operational and supply chain disruptions at key Saskatchewan mines, as evidenced by recent infrastructure washouts.
• AI data center capex digestion in the 2026–2027 window delaying the deployment of SMRs and new reactor builds.
• Geopolitical shifts that could unexpectedly reintroduce sanctioned Russian or Kazakh supply to Western markets, cooling the "security premium."
SPRO 0.3%
Full research note
Clinical-stage biotech developing tebipenem HBr for antibiotic-resistant infections.
Bull case · As a micro-cap, SPRO’s geometry permits multiplicative upside if its early‑stage antibiotic pipeline delivers positive clinical data. The calm macro regime and stable credit backdrop provide a benign environment for speculative biotech, and any positive catalyst could trigger a sharp re‑rating.
Bear case · The company lacks revenue, has deeply negative margins, and faces a high probability of dilutive financing. No analyst coverage, no recent intel, and a model conviction score in the bottom decile signal that the market is not pricing in any hidden value. A broader risk‑off event (carry unwind, Iran escalation) would disproportionately punish micro‑cap, non‑earning biotech names.
Key risks
• Binary clinical‑trial failure wiping out equity value.
• High cash burn requiring dilutive raises before potential derisking.
• Absence of any visible catalyst or insider confidence signal.
• Micro‑cap illiquidity amplifying drawdowns during macro stress.
• No fundamental moat — pipeline assets are early‑stage and unvalidated.
UEC 0.3%
Full research note
Uranium exploration and mining company facing regulatory and financing hurdles.
UUUU 0.3%
Full research note
Uranium and rare earths miner with unique blending capabilities and exposure to commodity cycles.
ALB 0.2%
Full research note
Albemarle produces lithium, bromine, and catalysts for energy storage and industrial markets.
TECK 0.2%
Full research note
Teck Resources mines copper, zinc, and coal for the global energy transition.
Bull case · Copper demand driven by energy transition and AI data center buildout provides multi-year structural tailwind. Strong balance sheet and capital discipline support shareholder returns, while recent share price momentum above the 200-day moving average signals institutional accumulation.
Bear case · Copper prices are under pressure from softening Chinese demand and rising LME inventories, while steelmaking coal faces structural decline. Large-cap size limits upside geometry, and the macro backdrop of elevated rates and geopolitical risk caps valuation multiples.
Key risks
• Copper price correction due to demand slowdown or macro recession
• Geopolitical escalation (Iran/Hormuz) disrupting global trade and risk appetite
• Commodity-sector rotation out of favor as equity market regime shifts to growth/tech
• Operational risks from mine disruptions, cost inflation, or environmental liabilities in multiple jurisdictions
CF 0.2%
Full research note
The dominant 30-day narrative for CF Industries centers on its massive windfall from the Iran-Hormuz conflict, which has severely curtailed Middle Eastern nitrogen and LNG exports. As the world's largest pure-play nitrogen producer with a structural cost advantage tied to cheap North American natural gas, CF is perfectly positioned to capture elevated global clearing prices. Following a blowout Q1 2026 earnings report ($3.98 EPS vs $2.63 expected), the market is hyper-focused on CF's ability to maximize asset utilization, highlighted by its strategic decision to delay maintenance at its Donaldsonville complex to supply an additional 100,000 tons of urea to a starved U.S. market.
Bull case · The strongest bull case rests on a "tighter for longer" nitrogen market combined with sharply bullish analyst revision flow. With Middle Eastern supply offline and European natural gas prices spiking, CF's North American cost advantage is generating massive free cash flow. This dynamic has triggered a powerful R19-T10 bullish revision-momentum signal, with consensus FY2026 EPS estimates surging over 70% in the last 60 days, while the Trump administration's recent permitting boost for CF's Blue Point low-carbon ammonia project adds a durable clean-energy growth vector.
Bear case · The bear case argues that CF's recent 50%+ YTD rally has fully priced in the geopolitical premium, leaving the stock highly vulnerable to a sudden de-escalation in the Middle East. If the Strait of Hormuz reopens and Middle Eastern capacity floods back into the market, global nitrogen prices will crater, rapidly compressing CF's currently inflated margins and triggering a cyclical mean-reversion selloff.
Key risks
• Geopolitical de-escalation in the Middle East rapidly normalizing global nitrogen supply.
• Cyclical mean-reversion risk following a massive 50%+ YTD rally.
• Volatility in North American natural gas prices eroding the company's structural cost advantage.
• Potential operational fatigue or unplanned outages after delaying critical maintenance at the Donaldsonville complex.
SQM 0.2%
Full research note
SQM produces specialty plant nutrients, iodine, lithium, potassium, and industrial chemicals.
HWM 0.1%
Full research note
Supplier of engineered aerospace components and fasteners, serving OEMs and aftermarket.
Bull case · The strongest sentiment-driven bull case revolves around Howmet's unassailable position in the single-crystal turbine blade duopoly and its accelerating free cash flow generation. Following the May 7 Q1 report, analysts have driven a sharply bullish revision flow (net +100.0% upward revisions over 30 days), reflecting confidence that Howmet's pricing power and operational efficiencies will continue to drive margin expansion. Furthermore, the market is increasingly pricing in a structural tailwind from the AI hardware buildout, as Howmet's IGT components are critical for powering new, energy-intensive data centers.
Bear case · The bear case focuses on valuation exhaustion and insider signaling, arguing that the stock is priced for perfection after a massive multi-year run. Bears point to the May 11 open-market sale of $11.3 million in stock by EVP Neil Marchuk just days after the Q1 earnings release as a sign that management sees limited near-term upside. Additionally, any prolonged production delays at Boeing or Airbus, combined with structurally higher discount rates, could trigger severe multiple compression for a stock trading at such a premium.
Key risks
• Insider selling cluster, highlighted by EVP Neil Marchuk's $11.3M sale on May 11 following the Q1 earnings beat.
• Valuation overhang, with the stock trading at a 54x P/E, leaving it vulnerable to multiple compression if growth decelerates.
• Customer concentration risk tied to Boeing and Airbus production ramps and potential supply chain disruptions.
• Margin compression threats from raw material (titanium, nickel) and energy cost inflation.
GE 0.1%
Full research note
GE Aerospace: a large-scale jet engine supplier with scale advantages and supply chain bottlenecks.
HII 0.1%
Full research note
Designs and builds military ships primarily for the U.S. Navy, with high customer concentration and long-term contracts.
SLV 0.1%
Full research note
Trust holding physical silver to reflect silver price performance.
Bull case · The strongest bullish sentiment anchors on the unprecedented industrial demand wave from AI infrastructure and newer TOPCon solar panels, which are structurally increasing silver intensity per unit. Proponents argue that with mine production severely constrained and consecutive years of global supply deficits, the current macro-driven selloff offers a generational entry point before physical shortages force a violent repricing.
Bear case · Bears point to the immediate macroeconomic reality: a structurally higher US dollar and elevated real yields under a hawkish Fed are crushing the monetary premium of precious metals. This has triggered massive volatility and forced liquidations, with the "safe haven" narrative unwinding rapidly amid potential Middle East de-escalation, leaving silver vulnerable to further downside if industrial demand softens in a recession.
Key risks
• Sustained hawkishness from the Federal Reserve driving real yields higher and accelerating ETF redemptions.
• A durable resolution to the Iran-Hormuz conflict draining the geopolitical safe-haven premium from precious metals.
• Technological substitution or "thrifting" in solar panel manufacturing reducing the silver intensity per cell.
• Intense fee competition from lower-cost physical silver ETFs eroding SLV's market share among retail investors.
BDL 0.1%
Full research note
Flanigan's Enterprises operates a chain of restaurants and entertainment venues with thin margins and no durable competitive advantage. The model projects modest long-term returns but with high probabilities of significant drawdowns, reflecting structural weaknesses in the business.
Bull case · BDL's micro-cap status and local presence might provide niche dominance in select markets; operational improvements or expansion could lift profitability. A low valuation and potential activist interest could unlock value.
Bear case · Intense restaurant industry competition with low barriers suppresses margins (gross 24%, operating 7%). Negative net cash ($24.3M USD) and a 4.2% ROE limit reinvestment and compound growth. our model's drawdown estimates (e.g., 15% chance of a 30% peak-to-trough over a decade) highlight significant downside risk.
Key risks
• Intense competitive pressures from both national chains and local eateries
• Cyclical consumer spending patterns vulnerable to economic downturns
• High financial leverage with net debt of $24.3M USD
• Small-cap illiquidity amplifying drawdowns and exit costs
• Lack of brand differentiation limiting pricing power

Track Record

The model's track record is young and, so far, mixed at best: across 41 days of scored ideas, one-day calls have produced positive alpha 54% of the time with an average essentially flat, while the one-week hit rate has slipped to 48%. The four-week cohort, a smaller set of 320 ideas, has been distinctly weak, with only 18% beating the market and average alpha of -6.9%, though that window is short enough that a few difficult weeks could dominate it. Every recommendation is written down before the outcome is known and scored when its horizon arrives, whether or not the result flatters the system, and the first three-month reads do not begin maturing until around September 13. With barely six weeks of history, the sample is thin enough that these figures describe a process still proving itself rather than a settled verdict.

18%
Hit rate
4w, n=320
-6.9%
Mean alpha (4w)
-6.5%
Mean return (4w)

Macro forecasts: 29 graded, 306 open — each call is scored against what actually happened when its horizon arrived.

Positions, conflicts & disclosures

DISCLAIMER — NOT INVESTMENT ADVICE (DECISION-LINKED)

This publication provides GENERAL and IMPERSONAL commentary and analysis on a regular schedule. The same content is provided to every subscriber. It is NOT investment advice, is NOT tailored to any individual, and does NOT account for your personal financial situation, objectives, or risk tolerance.

This post reports (1) a rules-based MODEL portfolio — target weights produced by an automated system's published rules, identical for all readers — and (2) DECISION-LINKED activity: how that affiliated automated system actually implemented, or has queued to implement, those rules in accounts belonging to the publication's operator. Model weights are not an account statement; the decision-linked positions and pending orders are REAL and belong to accounts affiliated with this publication's operator. We publish them for transparency on a fixed schedule under our Trading & Publication Policy [link] — not as a recommendation that any security or strategy is suitable for you. Because the publisher and/or operator hold or intend to establish positions in the securities discussed, a conflict of interest exists and our interests may differ from yours.

Nothing here is a recommendation to buy, sell, or hold any security for you specifically. Investing involves risk, including loss of principal. Past performance — model or actual — does not guarantee future results.

[Publisher LLC] is not a registered investment adviser and does not provide individualized investment advice. Consult a licensed professional before making any investment decision. See full disclosures, methodology, and our Trading & Publication Policy at [link].

POSITIONS DISCLOSURE: this is a hypothetical, rules-based model portfolio, not a statement of any individual's actual account; the publisher and/or author may hold positions in one or more of the securities listed.

CONFLICT OF INTEREST: because the publisher and/or author may hold listed securities, a conflict of interest exists and could benefit from price movements; the publisher receives no compensation for featuring any security, and this impersonal model illustration is not personalized investment advice or a solicitation to transact.

MICRO-CAP CAVEAT: some listed names are micro-capitalization securities held at small model weights; micro-caps carry elevated liquidity and volatility risk and are unsuitable for short-term trading — the small weights reflect that risk, and nothing here is a recommendation to scalp or rapidly trade thinly-traded securities.

Positions held: the publisher and/or operator currently holds positions in the following securities discussed here: ALB, CCJ, CF, COPX, DBC, DNN, FCX, FNV, GD, GDX, GE, HII, HWM, IAU, ICL, ITA, LAC, LDOS, LEU, LIT, LMT, LTPZ, MOS, MP, NOC, NTR, NXE, QUAL, REMX, RTX, SCCO, SCHP, SLV, SQM, STK, TECK, UEC, URA, URNM, UUUU, VTIP, WPM, XAR.

Disclaimer — not investment advice

This publication is a bona fide financial publication of general and regular circulation. It provides GENERAL and IMPERSONAL commentary and analysis only. The same content is provided to every reader on a regular schedule. It is NOT investment advice, is NOT tailored to any individual, and does NOT account for your personal financial situation, objectives, or risk tolerance.

Nothing here is a recommendation to buy, sell, or hold any security for you specifically. Any model portfolio described is a rules-based, hypothetical illustration provided to all readers identically — it is not a recommendation personalized to you. Investing involves risk, including loss of principal. Past performance — and any hypothetical or backtested performance — does not guarantee future results.

Clarke Envoy is not a registered investment adviser and does not provide individualized investment advice. Consult a licensed professional before making any investment decision.